Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 902

1.

VEGF in Signaling and Disease: Beyond Discovery and Development.

Apte RS, Chen DS, Ferrara N.

Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021. Review.

PMID:
30849371
2.

A Comprehensive Survey of Vision-Based Human Action Recognition Methods.

Zhang HB, Zhang YX, Zhong B, Lei Q, Yang L, Du JX, Chen DS.

Sensors (Basel). 2019 Feb 27;19(5). pii: E1005. doi: 10.3390/s19051005. Review.

3.

Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates with Early Recurrence and Aggressive Features of HBV-Associated HCC.

Li YT, Wu HL, Kao JH, Cheng HR, Ho MC, Wang CC, Chen PJ, Chen DS, Liu CJ.

Hepatology. 2019 Feb 25. doi: 10.1002/hep.30581. [Epub ahead of print]

PMID:
30802976
4.

Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection.

Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2019 Jan 29. doi: 10.1111/jgh.14615. [Epub ahead of print]

PMID:
30693965
5.

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH.

Aliment Pharmacol Ther. 2019 Mar;49(5):589-598. doi: 10.1111/apt.15132. Epub 2019 Jan 25.

PMID:
30681172
6.

Ly6C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice.

Wu LL, Peng WH, Wu HL, Miaw SC, Yeh SH, Yang HC, Liao PH, Lin JS, Chen YR, Hong YT, Wang HY, Chen PJ, Chen DS.

Hepatology. 2019 Jan 19. doi: 10.1002/hep.30510. [Epub ahead of print]

PMID:
30661248
7.

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH.

Aliment Pharmacol Ther. 2019 Feb;49(3):331-339. doi: 10.1111/apt.15101. Epub 2018 Dec 27.

PMID:
30592071
8.

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.

Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH.

PLoS One. 2018 Dec 21;13(12):e0209299. doi: 10.1371/journal.pone.0209299. eCollection 2018.

9.

Highly Efficient and Selective Dissolution Separation of Fission Products by an Ionic Liquid [Hbet][Tf2N]: A New Approach to Spent Nuclear Fuel Recycling.

Fan FL, Qin Z, Cao SW, Tan CM, Huang QG, Chen DS, Wang JR, Yin XJ, Xu C, Feng XG.

Inorg Chem. 2018 Dec 19. doi: 10.1021/acs.inorgchem.8b02783. [Epub ahead of print]

PMID:
30565939
10.

[The surgical management of upper parapharyngeal regions].

Wang XM, Li H, Chen DS, Lu ZY, Zhang MJ, Zhou LZ, Han YF, Wang WZ, Ma SY.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Dec 5;32(23):1804-1809. doi: 10.13201/j.issn.1001-1781.2018.23.009. Chinese.

PMID:
30550214
11.

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.

Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, Chen PJ, Chen DS.

J Formos Med Assoc. 2019 Feb;118(2):556-564. doi: 10.1016/j.jfma.2018.11.007. Epub 2018 Dec 5.

12.

[Effect of Quercetin on the Cell Cycle and Adhesion Molecules of NOD/SCID Mice with Acute B Lymphocytic Leukemia].

Wang L, Dai HW, Zheng J, Zhou J, Chen DS.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1616-1620. doi: 10.7534/j.issn.1009-2137.2018.06.006. Chinese.

PMID:
30501693
13.

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).

Kowanetz M, Zou W, Gettinger SN, Koeppen H, Kockx M, Schmid P, Kadel EE 3rd, Wistuba I, Chaft J, Rizvi NA, Spigel DR, Spira A, Hirsch FR, Cohen V, Smith D, Boyd Z, Miley N, Flynn S, Leveque V, Shames DS, Ballinger M, Mocci S, Shankar G, Funke R, Hampton G, Sandler A, Amler L, Mellman I, Chen DS, Hegde PS.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10119-E10126. doi: 10.1073/pnas.1802166115. Epub 2018 Oct 8.

14.

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T.

Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0235-z.

PMID:
30291359
15.

Contribution of Spinal PKCγ Expression to Short- and Long-lasting Pain Behaviors in Formalin-induced Inflamed Mice.

Zhao YQ, Yin JB, Wu HH, Ding T, Wang Y, Liang JC, Guo XJ, Tang K, Chen DS, Chen GZ.

Pain Physician. 2018 Sep;21(5):E555-E564.

16.

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.

Liu CH, Huang YJ, Yang SS, Chang CH, Yang SS, Sun HY, Liu CJ, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, Kao JH.

Sci Rep. 2018 Sep 12;8(1):13699. doi: 10.1038/s41598-018-32060-7.

17.

Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.

Liu CJ, Tseng TC, Yang WT, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2019 Feb;34(2):410-417. doi: 10.1111/jgh.14455. Epub 2018 Sep 20.

PMID:
30151861
18.

Combinations of Bevacizumab With Cancer Immunotherapy.

Chen DS, Hurwitz H.

Cancer J. 2018 Jul/Aug;24(4):193-204. doi: 10.1097/PPO.0000000000000327.

PMID:
30119083
19.

Introduction by the Guest Editors: Bevacizumab.

Ferrara N, Chen DS.

Cancer J. 2018 Jul/Aug;24(4):163-164. doi: 10.1097/PPO.0000000000000325. No abstract available.

PMID:
30119078
20.

Baicalin Attenuates Joint Pain and Muscle Dysfunction by Inhibiting Muscular Oxidative Stress in an Experimental Osteoarthritis Rat Model.

Chen DS, Cao JG, Zhu B, Wang ZL, Wang TF, Tang JJ.

Arch Immunol Ther Exp (Warsz). 2018 Dec;66(6):453-461. doi: 10.1007/s00005-018-0518-6. Epub 2018 Aug 3.

PMID:
30076457

Supplemental Content

Loading ...
Support Center